Omagari Katsumi, Mitomo Daisuke, Kubota Satoru, Nakamura Haruki, Fukunishi Yoshifumi
Japan Biological Informatics Consortium (JBiC), Koto-ku, Tokyo, Japan.
Adv Appl Bioinform Chem. 2008;1:19-28. doi: 10.2147/aabc.s3767. Epub 2008 Aug 12.
We examined the procedures to combine two different in silico drug-screening results to achieve a high hit ratio. When the 3D structure of the target protein and some active compounds are known, both structure-based and ligand-based in silico screening methods can be applied. In the present study, the machine-learning score modification multiple target screening (MSM-MTS) method was adopted as a structure-based screening method, and the machine-learning docking score index (ML-DSI) method was adopted as a ligand-based screening method. To combine the predicted compound's sets by these two screening methods, we examined the product of the sets (consensus set) and the sum of the sets. As a result, the consensus set achieved a higher hit ratio than the sum of the sets and than either individual predicted set. In addition, the current combination was shown to be robust enough for the structural diversities both in different crystal structure and in snapshot structures during molecular dynamics simulations.
我们研究了将两种不同的计算机辅助药物筛选结果相结合以获得高命中率的方法。当目标蛋白的三维结构和一些活性化合物已知时,基于结构和基于配体的计算机辅助筛选方法都可以应用。在本研究中,采用机器学习评分修正多靶点筛选(MSM-MTS)方法作为基于结构的筛选方法,采用机器学习对接评分指数(ML-DSI)方法作为基于配体的筛选方法。为了通过这两种筛选方法合并预测的化合物集,我们研究了这些集的乘积(共识集)和集的总和。结果,共识集比集的总和以及任何一个单独的预测集都具有更高的命中率。此外,目前的组合对于不同晶体结构以及分子动力学模拟中的快照结构的结构多样性都显示出足够的稳健性。